Find a company
| Project | Optimising Prostate Cancer Detection: Integrating QP-Prostate to Elevate Early Diagnosis Rates in NHS Pathways - Real-World Implementation Study |
|---|---|
| Description |
QP-Prostate® is a Software as a Medical Device (SaMD) designed to assist radiologists in reporting prostate MRI for patients suspected of having clinically significant prostate cancer (csPCa). Using T2w and DWI series from bpMRI/mpMRI studies, QP-Prostate® employs Artificial Intelligence (AI) to automatically identify and segment suspicious regions of interest (ROIs) for csPCa, providing confidence levels (High and Moderate) overlaid on axial T2w images for radiologist review. The software is trained and validated using biopsy outcomes (both targeted and systematic) as the ground truth, encompassing data from biopsy-naïve patients and those under active surveillance. |
| Funding | £ 2,599,917 |
| Competition | NHS Cancer Programme - Innovation Open Call 3 |
| Competition Date | April 2024 |
| Categories | Cancer |
| Health Innovation Network Partner | UCL Partners , Health Innovation West Midlands |
| Website | https://quibim.com/ |